ArticleBMC endocrine disorders2026
Early postoperative hyponatremia after pituitary adenoma surgery: risk factors, predictive model, and clinical implications.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveEarly postoperative hyponatremia (EPH, days 1–3) following pituitary neuroendocrine tumor (PitNET) surgery is a clinically significant complication with poorly defined risk factors. This study was designed to: (1) identify independent risk factors for EPH across all PitNET subtypes; (2) construct and validate a reliable predictive model using clinicopathological variables; and (3) develop a simplified risk scoring system to guide risk-stratified perioperative management.
methodsThis retrospective cohort study analyzed data from 300 adult patients who underwent PitNET surgery (January 2021 – December 2024) at Nanfang Hospital. Demographics, tumor characteristics (size, Knosp grade, functional type), preoperative conditions, and surgical details were collected. EPH was defined as serum sodium < 135 mmol/L within 1–3 days postoperatively. Multivariate binary logistic regression with stepwise selection (entry criterion P < 0.10, removal criterion P > 0.10) was used to identify independent risk factors and construct the predictive model. Model performance was evaluated by the area under the receiver operating characteristic curve (AUC), calibration plot, Hosmer-Lemeshow test, and bootstrap resampling (1000 iterations) for internal validation. The optimal risk score cutoff was determined by the Youden index. This study followed the STROBE guidelines.
resultsEPH occurred in 70 patients (23.3%). Five independent risk factors were identified: tumor diameter > 25 mm (OR = 2.85, 95% CI: 1.52–5.34, P = 0.001), Knosp grade ≥ 3 (OR = 3.10, 95% CI: 1.65–5.83, P < 0.001), adrenocorticotropic hormone (ACTH)-secreting tumor (OR = 3.55, 95% CI: 1.41–8.94, P = 0.007), preoperative hyponatremia (OR = 4.20, 95% CI: 1.81–9.74, P < 0.001), and operative duration > 180 min (OR = 2.15, 95% CI: 1.13–4.08, P = 0.019). The predictive model exhibited excellent discriminative ability (AUC = 0.85, 95% CI: 0.75–0.87) and adequate calibration (Hosmer-Lemeshow test: χ²=8.56, df = 8, P = 0.38), with robust performance confirmed by bootstrap validation (AUC = 0.83). A simplified risk scoring system (0–6 points) stratified patients into low- (0–1 points, EPH incidence 5.0%), medium- (2–3 points, 35.0%), and high-risk (≥ 4 points, 82.5%) groups. The optimal cutoff value (3 points) yielded a sensitivity of 78.6% and specificity of 83.9%.
conclusionTumor size (> 25 mm), invasiveness (Knosp grade ≥ 3), ACTH-secreting subtype, preoperative hyponatremia, and prolonged operative duration (> 180 min) are independent predictors of EPH. To our knowledge, this is the first comprehensive predictive model and simplified scoring system for EPH across all PitNET subtypes. The validated tool enables accurate preoperative risk stratification, facilitating personalized perioperative monitoring and targeted interventions to reduce EPH-related complications and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.